In addition, the role of atypical antipsychotics in neuroleptic-induced movement disorders is discussed, i.e. in their possible pros (consistent evidence that they are associated with fewer movement disorder side effects than typical antipsychotics) and cons (nonmotor side effects that have become ...
Some disorders coincide with other medical conditions that cause distress or impairment of a mental disorder, but that do not meet the full criteria for another mental disorder; these include other specified mental disorder due to another medical condition or unspecified mental disorder due to another...
Valbenazine (commercial name: Ingrezza) was the first drug approved for the treatment of tardive dyskinesia in 2017, a disorder in which patients experience involuntary movements of the face, limbs or trunk. Tardive dyskinesia is linked to the chronic treatment of conditions such as schizophrenia, ...
Medication-Induced Movement Disorders: Antidepressants and movement disorders In this column, I reviewed steps you can take to examine patients for antipsychotic-induced movement disorders and some diagnostic conundrums that are commonly encountered when evaluating for acute EPS. In my next column, I wi...
Lee MDPhD Myung Sik Lee MDJohn Wiley And Sons, Inc.Movement Disorders JS Baik,CH Lyoo,JH Lee,... - 《Movement Disorders Official Journal of the Movement Disorder Society》 被引量: 22发表: 2008年 Cabergoline for levodopa﹊nduced complications in Parkinson's disease Background Long term ...
56 To reduce the risk of a life-threatening skin rash, lamotrigine must be titrated slowly55,56 and should not be use as the first-line therapy in acute mania (as practical medications for mania must be titrated quickly to effect). For maintenance therapy in bipolar disorder, the initial ...
The primary endpoint was the change from baseline in scores on a measurement of motor ability called MDS-UPDRS, standing for Movement Disorder Society–Unified Parkinson’s disease Rating Scale, which ranges from zero to 132, with higher scores meaning greater disability. ...
A medication for heart problems and high blood pressure may also be effective for treating alcohol use disorder, according to a new study by researchers at the National Institutes of Health and their colleagues. The study presents converging evidence fro
The pathogenesis of the disorder a... None - 《Am J Psychiatry》 被引量: 315发表: 1980年 Miscellaneous treatments for neuroleptic-induced tardive dyskinesia Background Tardive dyskinesia is a disabling movement disorder associated with the prolonged use of neuroleptic medication. This review, one in...
Background:Medication-induced psychotic disorder (MIPD) is a diagnostic term for a syndrome with symptoms such as hallucinations and delusions directly related to drug intake. The purpose of this review is to report and comment on the current knowledge about pathomechanisms, risk factors, symptoms,...